Rennova Health, Inc. Warrant
RNVAZ
RNVAZ was delisted on the 24th of October, 2017.
0 hedge funds and large institutions have $0 invested in Rennova Health, Inc. Warrant in 2017 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and 4 closing their positions.
100% less funds holding
Funds holding: 4 → 0 (-4)
100% less capital invested
Capital invested by funds: $16K → $0 (-$16K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$6K |
| 2 |
VF
Virtu Financial
New York
|
-$6K |
| 3 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$4K |
RNVAZ Hedge Fund Activity: Q4 2017 in Review
0 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Rennova Health, Inc. Warrant (RNVAZ) for Q4 2017, worth a combined $0 — down 100% from $16K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of RNVAZ and 0 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Susquehanna International Group, exiting entirely with an estimated $6K sold.
- 0 institutional investors held Rennova Health, Inc. Warrant (RNVAZ) as of Q4 2017, down from 4 in Q3 2017.
- Funds reported $0 of Rennova Health, Inc. Warrant stock for Q4 2017, down 100% quarter-over-quarter.
- 0 funds opened new Rennova Health, Inc. Warrant positions in Q4 2017 and 4 closed out, a net change of -4 holders.
- The largest Rennova Health, Inc. Warrant seller in Q4 2017 was Susquehanna International Group, an estimated $6K sold.
Based on aggregated 13F filings for Q4 2017.